Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
dexmedetomidine hydrochloride, Quantity: 118 microgram/mL (Equivalent: dexmedetomidine, Qty microgram/mL)
Accord Healthcare Pty Ltd
Injection, concentrated
Excipient Ingredients: sodium chloride; water for injections
Intravenous
1, 5, 25
(S4) Prescription Only Medicine
ICU Sedation: For sedation of initially intubated adult patients during treatment in an intensive care setting. The use of Dexmedetomidine Accord by continuous infusion in these patients should not exceed 24 hours.,Procedural Sedation: For sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
Visual Identification: A clear, colourless solution in a glass vial.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2019-06-18
Version 2.0 Page 1 of 3 DEXMEDETOMIDINE ACCORD _Dexmedetomidine (as hydrochloride) Concentrated Injection 200 micrograms/2 mL _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Dexmedetomidine Accord. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits . Your doctor has weighed the risks of you taking Dexmedetomidine Accord against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT DEXMEDETOMIDINE ACCORD IS USED FOR _INTENSIVE CARE SEDATION _ Dexmedetomidine Accord can be used as a sedative (calming agent) if adults need to be calm or sleepy in the Intensive Care Unit whilst they are being ventilated (on a breathing machine). It may be given as an infusion up to 24 hours. _PROCEDURAL SEDATION _ Dexmedetomidine Accord can be given to adults prior to an operation if they are not on a ventilator (breathing machine) if it is required for the procedure or surgery that they be sleepy and calm. This medicine belongs to a group of medicines called alpha-2-receptor agonists. This medicine works by its actions on brain chemicals. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. Dexmedetomidine Accord is only available with a doctor’s prescription. BEFORE YOU ARE GIVEN DEXMEDETOMIDINE ACCORD _WHEN YOU MUST NOT BE _ _GIVEN IT _ DO NOT TAKE DEXMEDETOMIDINE ACCORD IF YOU HAVE AN ALLERGY TO: • any medicine containing dexmedetomidine hydrochloride • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin DO Đọc toàn bộ tài liệu
Page 1 of 17 AUSTRALIAN PRODUCT INFORMATION DEXMEDETOMIDINE ACCORD (DEXMEDETOMIDINE HYDROCHLORIDE) CONCENTRATED INJECTION 1 NAME OF THE MEDICINE Dexmedetomidine hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Dexmedetomidine Accord concentrated injection is a sterile, non-pyrogenic solution suitable for intravenous infusion. Dexmedetomidine hydrochloride is a white or almost white powder, freely soluble in water and its pKa is 7.1. The partition coefficient in octanol: water at pH 7.84 is 2.89. Each 2 mL of Dexmedetomidine Accord contains 236 micrograms of dexmedetomidine hydrochloride (equivalent to 200 micrograms dexmedetomidine base) and 18 mg of sodium chloride in water for injections. The solution is preservative-free and contains no additives or chemical stabilisers. 3 PHARMACEUTICAL FORM Dexmedetomidine Accord is a clear, colourless, isotonic solution with a pH of 4.5 to 7.0. Dexmedetomidine Accord is presented in 2 mL vials and must be diluted prior to use. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS ICU SEDATION For sedation of initially intubated patients during treatment in an intensive care setting. The use of Dexmedetomidine Accord by continuous infusion in these patients should not exceed 24 hours. PROCEDURAL SEDATION For sedation of non-intubated patients prior to and/or during surgical and other procedures . 4.2 D OSE AND METHOD OF ADMINISTRATION _NOTE: _ Dexmedetomidine should be administered only by persons skilled in anaesthetics or in the management of patients in the intensive care setting. Due to the known pharmacological effects, patients should be continuously monitored. Clinically significant events of bradycardia and sinus arrest have been associated with dexmedetomidine hydrochloride administration in young, healthy volunteers with high vagal tone or with different routes of administration including rapid intravenous or bolus administration of dexmedetomidine hydrochloride. _Adults_ : Dexmedetomidine should be individualised and titrated to the desired clinical effect. Đọc toàn bộ tài liệu